SCN5A and amyotrophic lateral sclerosis: Among the latter category of genes, neither SCN5A nor SLC7A11, which encode proteins targeted by Riluzole, a drug approved for ALS treatment [11], are found in the landscape, as they are not genetically linked to ALS and encode proteins modulated as part of a symptomatic treatment for ALS [11,12].